A detailed history of Reap Financial Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Reap Financial Group, LLC holds 270 shares of ABT stock, worth $36,684. This represents 0.01% of its overall portfolio holdings.

Number of Shares
270
Previous 289 6.57%
Holding current value
$36,684
Previous $33 Million 7.33%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 27, 2025

SELL
$111.93 - $119.39 $2,126 - $2,268
-19 Reduced 6.57%
270 $30.6 Million
Q3 2024

Feb 27, 2025

BUY
$100.07 - $118.13 $7,705 - $9,096
77 Added 36.32%
289 $33 Million
Q2 2024

Feb 27, 2025

BUY
$100.73 - $112.44 $100 - $112
1 Added 0.47%
212 $22 Million
Q1 2024

Feb 27, 2025

SELL
$109.52 - $120.96 $63,521 - $70,156
-580 Reduced 73.32%
211 $23.9 Million
Q4 2023

Feb 27, 2025

BUY
$90.19 - $110.4 $71,340 - $87,326
791 New
791 $87 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $238B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Reap Financial Group, LLC Portfolio

Follow Reap Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Reap Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Reap Financial Group, LLC with notifications on news.